Healthcare - Biotechnology - NASDAQ - US
$ 0.6701
-6.12 %
$ 25.9 M
Market Cap
-0.24
P/E
BALANCE SHEET
160 M
ASSETS
30.1 M
LIABILITIES
130 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Athira Pharma, Inc.
| Current Assets | 155 M |
| Cash & Short-Term Investments | 147 M |
| Receivables | 1.63 M |
| Other Current Assets | 5.68 M |
| Non-Current Assets | 5.52 M |
| Long-Term Investments | 0 |
| PP&E | 4.44 M |
| Other Non-Current Assets | 1.08 M |
| Current Liabilities | 28.8 M |
| Accounts Payable | 129 K |
| Short-Term Debt | 736 K |
| Other Current Liabilities | 28 M |
| Non-Current Liabilities | 1.22 M |
| Long-Term Debt | 1.22 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 90.6 | 96.0 | 110.5 | 60.6 | 2.1 | 3.3 |
| Short Term Investments | 56.8 | 104.4 | 143.2 | 124.1 | 0 | 1.5 |
| Receivables | 1.6 | 1.2 | 2.3 | 1.3 | 7 K | 6 K |
| Inventory | 0 | (1.2) | (2.3) | (1.3) | 0 | 0 |
| Other Current Assets | 5.7 | 6.0 | 4.7 | 6.4 | 97 K | 74 K |
| Total Current Assets | 154.7 | 207.5 | 260.8 | 192.3 | 2.2 | 4.9 |
| PP&E | 4.4 | 5.3 | 5.2 | 3.6 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 44.8 | 65.9 | 83.5 | 29 K | 36 K |
| Other Long Term Assets | 1.1 | 0.5 | 56 K | 0.1 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 160.2 | 258.2 | 332.0 | 279.6 | 2.2 | 4.9 |
| LIABILITIES | ||||||
| Accounts Payable | 0.1 | 2.5 | 0.6 | 1.2 | 0.4 | 0.1 |
| Short Term Debt | 0.7 | 0.7 | 0.6 | 0.2 | 0 | 0 |
| Other Current Liabilities | 28.0 | 18.3 | 8.1 | 3.0 | 0.9 | 0.5 |
| Total Current Liabilities | 28.8 | 21.4 | 9.3 | 4.4 | 1.3 | 0.6 |
| Long Term Debt | 1.2 | 1.6 | 1.6 | 0.9 | 1.6 | 0.7 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 19.1 | 18.5 |
| Total Liabilities | 30.1 | 23.0 | 10.9 | 5.3 | 21.9 | 19.8 |
| EQUITY | ||||||
| Common Stock | 4 K | 4 K | 4 K | 3 K | 3 K | 3 K |
| Retained Earnings | (309.2) | (191.5) | (95.9) | (41.0) | (21.1) | (15.9) |
| Other Accumulative Comprehensive Income/Loss | (0.3) | (2.0) | (0.4) | 33 K | (17.1) | (17.1) |
| Total Equity | 130.2 | 235.1 | 321.1 | 274.3 | (19.7) | (14.9) |
| Total Liabilities and Equity | 160.2 | 258.2 | 332.0 | 279.6 | 2.2 | 4.9 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 38.0 | 37.7 | 36.9 | 32.5 | 32.6 | 6.2 |